ENCLOSURE ISSUED BY THE ENTITLED SUSPENSION OF INTRODUCTION OF PERSONS INTO UNITED STATES FROM DESIGNATED FOREIGN COUNTRIES OR PLACES FOR PUBLIC HEALTH PURPOSES”
(i) Cost-benefit analysis
In its submission to us, the Department of Health and Human Services (HHS) on behalf of the Centers for Disease Control and Prevention (CDC) indicated that it did not prepare an analysis of the costs and benefits of this interim final rule (IFR).
(ii) Agency actions relevant to the Regulatory Flexibility Act (RFA), 5 U.S.C. §§ 603-605, 607, and 609
In its submission to us, HHS indicated that a regulatory flexibility analysis was not prepared for this IFR. However, according HHS, when a rule is